(E)-6-ethoxy-2-(2-((1-methyl-1H-pyrrol-2-yl)methylene)hydrazineyl)-3-nitropyridine

ID: ALA5286281

Max Phase: Preclinical

Molecular Formula: C13H15N5O3

Molecular Weight: 289.30

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCOc1ccc([N+](=O)[O-])c(N/N=C/c2cccn2C)n1

Standard InChI:  InChI=1S/C13H15N5O3/c1-3-21-12-7-6-11(18(19)20)13(15-12)16-14-9-10-5-4-8-17(10)2/h4-9H,3H2,1-2H3,(H,15,16)/b14-9+

Standard InChI Key:  LMDXCUDSGQRSPY-NTEUORMPSA-N

Molfile:  

 
     RDKit          2D

 21 22  0  0  0  0  0  0  0  0999 V2000
    1.4754    0.8248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7609    1.2374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0465    0.8248    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6678    1.2374    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3823    0.8248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3823   -0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0922   -0.4117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8083   -0.0037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8083    0.8245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0939    1.2366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0939    2.0616    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3795    2.4740    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8084    2.4740    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0922   -1.2367    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3777   -1.6491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3777   -2.4740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1898    1.2373    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8084    0.6661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4777   -0.0681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6538    0.0241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1898    2.0623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  2  0
  4  3  1  0
  5  4  1  0
  6  5  2  0
  7  6  1  0
  8  7  2  0
  9  8  1  0
 10  9  2  0
  5 10  1  0
 11 10  1  0
 11 12  1  0
 11 13  2  0
  7 14  1  0
 14 15  1  0
 15 16  1  0
 17  1  1  0
 17 18  1  0
 18 19  2  0
 20 19  1  0
  1 20  2  0
 17 21  1  0
M  CHG  2  11   1  12  -1
M  END

Alternative Forms

  1. Parent:

    ALA5286281

    ---

Associated Targets(Human)

MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 289.30Molecular Weight (Monoisotopic): 289.1175AlogP: 2.17#Rotatable Bonds: 6
Polar Surface Area: 94.58Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.45CX Basic pKa: 3.56CX LogP: 3.78CX LogD: 3.78
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.50Np Likeness Score: -2.24

References

1. Manzoor S, Hoda N..  (2020)  A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review.,  206  [PMID:32942081] [10.1016/j.ejmech.2020.112787]

Source